The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
CRISPR Editing Alters Flower Color
The ability to change the color of the Japanese morning glory demonstrates the specificity of the CRISPR-Cas9 gene editing system.
How Blood Stem Cells Are Controlled By Epigenetics
Using RNA sequencing techniques, researchers in China have revealed how embryonic hematopoietic stem cell production is controlled by epigenetic regulation.
WuXi Raises US$240 Million In Series B Funding
The investment will accelerate the growth of WuXi NextCODE's platform infrastructure and bring new users onboard through precision medicine and diagnostics partnerships.
A Cheap Way To Make Materials Repel Both Water And Oil
By melting the top of cylindrical posts, researchers have created mushroom-shaped nanostructures that give materials the ability to repel both water and oil.
China Fires Up Its First Neutron Beam
The China Spallation Neutron Source has successfully produced a neutron beam for the first time.
Why Arctic Sea Ice Is In Rapid Retreat
As dark ocean surfaces absorb more light than white ice surfaces, solar heat input through the open water melts sea ice.
Contagious Yawning Not About Empathy
Perceptual sensitivity instead of empathy determines vulnerability to contagious yawning, scientists in Japan show.
Nanocapsules Selectively Sequester Sucrose
Researchers in Japan have developed a nanocapsule that recognizes and encapsulates sucrose while excluding other natural sugars.
Avatars For Personalized Cancer Treatment
Researchers have grown micro-tumor models using patients’ cancer cells to identify more effective treatments for drug-resistant tumors.









